Ticker Scorecard - VRDN Basics Company: Viridian Therapeutics, Inc. IPO Date: June 16, 2014 Sector: Healthcare Industry: Biotech Market Cap: $1.29B Activated in VL: True Average Daily Range Avg Daily Range: $0.52 | 2.83% Avg Daily Range (30 D): $0.48 | 2.60% Avg Daily Range (90 D): $0.52 | 2.51% Institutional Daily Volume Avg Daily Volume: .51M Avg Daily Volume (30 D): .87M Avg Daily Volume (90 D): .97M Trade Size Avg Trade Size (Sh.): 70 Avg Trade Size (Sh.) (30 D): 64 Avg Trade Size (Sh.) (90 D): 66 Institutional Trades Total Inst.Trades: 1,472 Avg Inst. Trade: $1.99M Avg Inst. Trade (30 D): $2.02M Avg Inst. Trade (90 D): $2.63M Avg Inst. Trade Volume: .1M Avg Inst. Trades (Per Day): 2 Market Closing Trades Avg Closing Trade: $2.78M Avg Closing Trade (30 D): $2.91M Avg Closing Trade (90 D): $3.66M Avg Closing Volume: 145.09K     News Oct 15, 2024 @ 3:45 PM Ophthalmic Disease Therapeutics Market Analysis by... Source: Researchandmarkets.Com Jul 4, 2024 @ 8:01 PM Thyroid Eye Disease Market to Accelerate Substanti... Source: Delveinsight Jun 6, 2024 @ 3:00 PM 7 Analysts Assess Viridian Therapeutics: What You ... Source: Benzinga Insights May 8, 2024 @ 12:25 PM Viridian Therapeutics, Inc. (VRDN) Reports Q1 Loss... Source: Zacks Equity Research Mar 20, 2024 @ 6:00 PM Unveiling 4 Analyst Insights On Viridian Therapeut... Source: Benzinga Insights Financials   TTM Q2 2024 Q1 2024 Basic EPS $-1.15 $-1.02 $-.79 Diluted EPS $-1.15 $-1.02 $-.79 Revenue $ .09M $ .07M $ .07M Gross Profit $ $ $ Net Income / Loss $ -76.69M $ -64.99M $ -48.54M Operating Income / Loss $ -83.48M $ -72.19M $ -55.9M Cost of Revenue $ $ $ Net Cash Flow $ 92.65M $ 16.03M $ -11.19M PE Ratio     Splits Nov 13, 2020:   15:1 Nov 07, 2016:   15:1